EORTC 2335-GUCG BRACE Study Reaches First-Patient Milestone
EORTC/ X

EORTC 2335-GUCG BRACE Study Reaches First-Patient Milestone

European Organisation for Research and Treatment of Cancer (EORTC) shared on X:

“The European Organisation for Research and Treatment of Cancer 2335-GUCG BRACE study has reached an important milestone with the inclusion of its first patient.

Congratulations to all study coordinators, investigators and research teams involved, as well as to the first patient participating in the study.”

EORTC 2335-GUCG BRACE Study Reaches First-Patient Milestone

You can also read:

World Cancer Research Day: 10 Years of Progress, Innovation, and Collaboration

EORTC 2335-GUCG BRACE Study Reaches First-Patient Milestone